Skip to content

Portable Ultrasound to Predict Heart Failure Readmission Risk

Utility and Feasibility of Prehospital Portable Ultrasound to Predict Heart Failure Readmission Risk

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05980533
Enrollment
0
Registered
2023-08-08
Start date
2024-12-30
Completion date
2026-12-30
Last updated
2025-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Patient Readmission

Keywords

Ultrasound

Brief summary

The purpose of this research is to use a handheld ultrasound to assess patients with congestive heart failure (CHF) to see if the ultrasound can help predict readmission to the hospital. The study will include patients who are admitted to the hospital for CHF. Participants will have two ultrasounds at hospital discharge and at a follow up visit.

Detailed description

The purpose of this research is to see if a portable ultrasound can help predict readmission to the hospital for patients who are admitted to the hospital for CHF. The study will enroll patients who take part in Mobile Integrated Healthcare as part of their routine care. Participants will have two ultrasounds. The first ultrasound will be at hospital discharge. Between seven to ten days after hospital discharge participants will be visited at their home in follow-up as the usual standard of care for Mobile Integrated Healthcare. At this visit participants will have a second ultrasound. Participants will be followed for one year for hospital readmission.

Interventions

DIAGNOSTIC_TESTUltrasound

Ultrasound at hospital discharge and at follow up at 7-10 days

Sponsors

The Guthrie Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Primary admission diagnosis is listed as congestive heart failure, with an acute component of decompensation. * Age greater than 18 years. * Principal residence within the geographic reach of our MIH program.

Exclusion criteria

* pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Hospital Readmission30 daysHospital readmission within 30 days of discharge

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026